Anteana Therapeutics Inc Profile last edited on: 3/4/19
CAGE: 6VQP5
UEI: F2QBDJHRH2G3
Business Identifier: Chronic pain and inflammation management involving NAAA Inhibitors. 
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.
Location Information
11189 Sorrento Valley Road # 104
San Diego, CA 92121
San Diego, CA 92121
| (858) 449-4339 |
| N/A |
| N/A |
Location: Single
Congr. District: 52
County: San Diego
Congr. District: 52
County: San Diego
Public Profile
Anteana Therapeutics Inc works in developing chronic pain and inflammation therapies involving inhibitors of N-acylethanolamine acid amide hydrolase (NAAA) molecules. The company grew out of research conducted by neuroscientist Daniele Piomelli at the University of California, Irvine, as well as the work of Dr. Miguel Garcia-Guzman, a specialist in pain pathologies and drug development.
Extent of SBIR involvement
Synopsis: Awardee Business Condition
Employee Range
1-4Revenue Range
Less than .5MVC funded?
NoPublic/Private
Privately HeldStock Info
----IP Holdings
20-24Awards Distribution by Agency
Most Recent SBIR Projects
| Year | Phase | Agency | Total Amount | |
|---|---|---|---|---|
| 2019 | 2 | NIH | $1,631,132 | |
| Project Title: Peripheral Faah as a Target for Novel Analgesics | ||||
| 2019 | 2 | NIH | $1,207,398 | |
| Project Title: Naaa Inhibitors for Pain and Inflammation | ||||
| 2015 | 1 | NIH | $150,000 | |
| Project Title: A New Treatment for Nsaid-Associated Gastrointestinal Damage | ||||
Key People / Management
Michael Salka -- Chief Executive Officer
Miguel Garcia-Guzman -- Scientific Founder and Head of Drug Discovery and Biology
Roger Heim
Edward Paul Monaghan -- Chief Development Officer
Daniele Piomelli
Miguel Garcia-Guzman -- Scientific Founder and Head of Drug Discovery and Biology
Roger Heim
Edward Paul Monaghan -- Chief Development Officer
Daniele Piomelli
Company News
There are no news available.
